ConductScience.org, home

Paper8013282

The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.

Fischer V and 6 others. Drug Metab Dispos, 1994. Cited by 90 papers, by iCite.

Cite this record

ConductScience Library. The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron. Papers, record 8013282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8013282

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The polymorphic cytochrome P-4502D6 is involved in the metabolism of both 5-hydroxytryptamine antagonists, tropisetron and ondansetron.
PubMed
Journal
Drug Metab Dispos
PubMed
Year
1994
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
90
iCite
Relative citation ratio, by iCite
3.95
iCite
Revised in PubMed
2018-11-30
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fischer VV
2Vickers AEA E
3Heitz FF
4Mahadevan SS
5Baldeck JPJ P
6Minery PP
7Tynes RR

Source PubMed

Download CSV of authors

Topics20

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytochrome P-450 Enzyme SystemMajor topic
IndolesMajor topic
Mixed Function OxygenasesMajor topic
OndansetronMajor topic
Serotonin AntagonistsMajor topic
Animals
CHO Cells
Cells, Cultured
Chromatography, High Pressure Liquid
Cricetinae
Cyclosporine
Cytochrome P-450 CYP2D6
Cytochrome P-450 Enzyme Inhibitors
Humans
Hydroxylation
In Vitro Techniques
Liver
Microsomes, Liver
Spectrometry, Mass, Fast Atom Bombardment
Tropisetron

Source PubMed

Download CSV of topics

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.

PMIDTitleJournalYearIn PapersSource
41979467Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 Genotype and Use of 5-HT3 Receptor Antagonists: 2026 Update.Clin Pharmacol Ther2026https://conductscience.org/library/papers/41979467PubMed
38882995Prevalence, Attributes, and Risk Factors of QT-Interval-Prolonging Drugs and Potential Drug-Drug Interactions in Cancer Patients: A Prospective Study in a Tertiary Care Hospital.Cureus2024https://conductscience.org/library/papers/38882995PubMed
37375836Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug-Gene Pairs to Know.Pharmaceuticals (Basel)2023https://conductscience.org/library/papers/37375836PubMed
37223851Simulation of drug-drug interactions between breast cancer chemotherapeutic agents and antiemetic drugs.Daru2023https://conductscience.org/library/papers/37223851PubMed
36597259CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.Expert Opin Drug Metab Toxicol2022https://conductscience.org/library/papers/36597259PubMed
36350309Pediatric CYP2D6 metabolizer status and post-tonsillectomy nausea and vomiting after ondansetron.Clin Transl Sci2023https://conductscience.org/library/papers/36350309PubMed
36229874Experimentally designed electrochemical sensor for therapeutic drug monitoring of Ondansetron co-administered with chemotherapeutic drugs.BMC Chem2022https://conductscience.org/library/papers/36229874PubMed
35344639Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator.CPT Pharmacometrics Syst Pharmacol2022https://conductscience.org/library/papers/35344639PubMed
34670017Influence of CYP2D6 metabolizer status on ondansetron efficacy in pediatric patients undergoing hematopoietic stem cell transplantation: A case series.Clin Transl Sci2022https://conductscience.org/library/papers/34670017PubMed
30672837PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics.Pharmacogenet Genomics2019https://conductscience.org/library/papers/30672837PubMed
28002639Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron.Clin Pharmacol Ther2017https://conductscience.org/library/papers/28002639PubMed
27988869Comparative Pharmacology and Guide to the Use of the Serotonin 5-HT3 Receptor Antagonists for Postoperative Nausea and Vomiting.Drugs2016https://conductscience.org/library/papers/27988869PubMed
23512709Does pharmacogenomics account for variability in control of acute chemotherapy-induced nausea and vomiting with 5-hydroxytryptamine type 3 receptor antagonists?Curr Oncol Rep2013https://conductscience.org/library/papers/23512709PubMed
19902987Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.Clin Pharmacokinet2009https://conductscience.org/library/papers/19902987PubMed
19817501Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I.Clin Pharmacokinet2009https://conductscience.org/library/papers/19817501PubMed
15740177Selective serotonin 5-HT3 receptor antagonists for postoperative nausea and vomiting: are they all the same?CNS Drugs2005https://conductscience.org/library/papers/15740177PubMed
12799621Current position of 5HT3 antagonists and the additional value of NK1 antagonists; a new class of antiemetics.Br J Cancer2003https://conductscience.org/library/papers/12799621PubMed
12728290Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects.Eur J Clin Pharmacol2003https://conductscience.org/library/papers/12728290PubMed
10319191Polymorphic cytochromes P450 and drugs used in psychiatry.Cell Mol Neurobiol1999https://conductscience.org/library/papers/10319191PubMed
9723819Population pharmacokinetics of ondansetron: a covariate analysis.Br J Clin Pharmacol1998https://conductscience.org/library/papers/9723819PubMed

See all 27 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CYP2C191557PubTator's text mininghttps://conductscience.org/library/genes/1557NCBI Gene
CYP2D61565PubTator's text mininghttps://conductscience.org/library/genes/1565NCBI Gene
CYP2E11571PubTator's text mininghttps://conductscience.org/library/genes/1571NCBI Gene
CYP3A41576PubTator's text mininghttps://conductscience.org/library/genes/1576NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8013282

GET https://conductscience.org/api/papers/v1/8013282/cited_by?page=2